TY - JOUR
T1 - Clinical and technical factors associated with knee radiofrequency ablation outcomes
T2 - A multicenter analysis
AU - Chen, Yian
AU - Vu, To Nhu H.
AU - Chinchilli, Vernon M.
AU - Farrag, Mohamed
AU - Roybal, Alexandra R.
AU - Huh, Albert
AU - Cohen, Zared O.
AU - Becker, Adam B.
AU - Arvanaghi, Babak
AU - Agrawal, Mrinal
AU - Ogden, Jacob
AU - Cohen, Steven P.
N1 - Funding Information:
Funding Funded in part by a grant from MIRROR, Uniformed Services University of the Health Sciences, US Dept. of Defense, and grant # HU00011920011.
Publisher Copyright:
©
PY - 2021/4/1
Y1 - 2021/4/1
N2 - Background There has been a surge in interest in radiofrequency ablation (RFA) of the genicular nerves over the past decade, with wide variability in selection, technique and outcomes. The aim of this study is to determine factors associated with treatment outcome. Methods We retrospectively evaluated the effect of 23 demographic, clinical and technical variables on outcomes in 265 patients who underwent genicular nerve RFA for knee pain at 2 civilian and 1 military hospital. A primary outcome was designated as a > 30% decrease in average knee pain score lasting at least 3 months without cointerventions. Results The overall rate of a positive response was 61.1% (95% CI 55.2% to 67.0%). In univariable analysis, larger electrode size (p=0.01), repeated lesions (p=0.02), having>80% pain relief during the prognostic block (p=0.02), not being on opioids (p=0.04), having no coexisting psychiatric condition (p=0.02), having a lower baseline pain score (p=0.01) and having >3 nerves targeted (p=0.02) were associated with a positive outcome. In multivariate logistic analysis, being obese (OR 3.68, 95% CI 1.66 to 8.19, p=0.001), not using opioids (OR 0.35, 95% CI 0.16 to 0.77, p=0.009), not being depressed (OR 0.29, 95% CI 0.10 to 0.82, p=0.02), use of cooled RFA (OR 3.88, 95% CI 1.63 to 9.23, p=0.002) and performing multiple lesions at each neural target (OR 15.88, 95% CI 4.24 to 59.50, p<0.001) were associated with positive outcome. Conclusions We identified multiple clinical and technical factors associated with treatment outcome, which should be considered when selecting patients for RFA treatment and in the design of clinical trials.
AB - Background There has been a surge in interest in radiofrequency ablation (RFA) of the genicular nerves over the past decade, with wide variability in selection, technique and outcomes. The aim of this study is to determine factors associated with treatment outcome. Methods We retrospectively evaluated the effect of 23 demographic, clinical and technical variables on outcomes in 265 patients who underwent genicular nerve RFA for knee pain at 2 civilian and 1 military hospital. A primary outcome was designated as a > 30% decrease in average knee pain score lasting at least 3 months without cointerventions. Results The overall rate of a positive response was 61.1% (95% CI 55.2% to 67.0%). In univariable analysis, larger electrode size (p=0.01), repeated lesions (p=0.02), having>80% pain relief during the prognostic block (p=0.02), not being on opioids (p=0.04), having no coexisting psychiatric condition (p=0.02), having a lower baseline pain score (p=0.01) and having >3 nerves targeted (p=0.02) were associated with a positive outcome. In multivariate logistic analysis, being obese (OR 3.68, 95% CI 1.66 to 8.19, p=0.001), not using opioids (OR 0.35, 95% CI 0.16 to 0.77, p=0.009), not being depressed (OR 0.29, 95% CI 0.10 to 0.82, p=0.02), use of cooled RFA (OR 3.88, 95% CI 1.63 to 9.23, p=0.002) and performing multiple lesions at each neural target (OR 15.88, 95% CI 4.24 to 59.50, p<0.001) were associated with positive outcome. Conclusions We identified multiple clinical and technical factors associated with treatment outcome, which should be considered when selecting patients for RFA treatment and in the design of clinical trials.
KW - chronic pain
KW - diagnostic techniques and procedures
KW - nerve block
KW - pain management
KW - treatment outcome
UR - http://www.scopus.com/inward/record.url?scp=85099795063&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85099795063&partnerID=8YFLogxK
U2 - 10.1136/rapm-2020-102017
DO - 10.1136/rapm-2020-102017
M3 - Article
C2 - 33558282
AN - SCOPUS:85099795063
SN - 1098-7339
VL - 46
SP - 298
EP - 304
JO - Regional Anesthesia and Pain Medicine
JF - Regional Anesthesia and Pain Medicine
IS - 4
ER -